These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23291063)

  • 1. [Silencing effect of cell-specific RNA interference plasmid pPSMAe/p-shNS-ploy(A) loaded by transgenic vector Tf-PEG-PEI targeting nucleostemin on prostate cancer cells in vitro].
    Liu RL; Wang WY; Zhang ZH; Xu Y
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):725-9. PubMed ID: 23291063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
    Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
    Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
    Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
    Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
    Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
    Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
    Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.
    Langut Y; Talhami A; Mamidi S; Shir A; Zigler M; Joubran S; Sagalov A; Flashner-Abramson E; Edinger N; Klein S; Levitzki A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13655-13660. PubMed ID: 29229829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
    Guo J; O'Driscoll CM; Holmes JD; Rahme K
    Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
    Liu R; Zhang Z; Xu Y
    Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
    Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
    J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PEG-transferrin-PEI nanocomplex as a gene delivery agent.
    Lee KM; Lee YB; Oh IJ
    J Nanosci Nanotechnol; 2011 Aug; 11(8):7078-81. PubMed ID: 22103128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.
    Liu YY; Yang XY; Li Z; Liu ZL; Cheng D; Wang Y; Wen XJ; Hu JY; Liu J; Wang LM; Wang HJ
    CNS Neurosci Ther; 2014 Jan; 20(1):76-85. PubMed ID: 24279586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
    Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
    Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
    Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
    Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo Z; Lai Y; Du T; Zhang Y; Chen J; Bi L; Lin T; Liu H; Wang W; Xu K; Jiang C; Han J; Zhang C; Dong W; Huang J; Huang H
    Chin Med J (Engl); 2014; 127(5):929-36. PubMed ID: 24571890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Silencing nucleostemin expression reduces the proliferation of PC-3 cells].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2009 Jul; 15(7):593-8. PubMed ID: 19694370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide GE11-Polyethylene Glycol-Polyethylenimine for targeted gene delivery in laryngeal cancer.
    Ren H; Zhou L; Liu M; Lu W; Gao C
    Med Oncol; 2015 Jul; 32(7):185. PubMed ID: 26008151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer.
    Zhao Y; Lee RJ; Liu L; Dong S; Zhang J; Zhang Y; Yao Y; Lu J; Meng Q; Xie J; Teng L
    Int J Pharm; 2019 Jun; 564():214-224. PubMed ID: 31004717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.